Related Experiment Video

Updated: Apr 20, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

18.1K

Isolated left ventricular non-compaction cardiomyopathy in adults

Uichi Ikeda1, Masatoshi Minamisawa1, Jun Koyama1

  • 1Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Japan.

Journal of Cardiology
|December 4, 2014
PubMed

Insights

Left ventricular non-compaction (LVNC) is a rare heart muscle disorder. Further multicenter studies are needed to understand its prevalence and guide management for this condition.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Heart Muscle Diseases

Background:

  • Left ventricular non-compaction (LVNC) is a myocardial disorder characterized by prominent trabeculations and deep recesses.
  • A universally accepted definition and clear prevalence data for LVNC are currently lacking.
  • Diagnostic advancements have led to increased identification of LVNC cases.

Purpose of the Study:

  • To review the current understanding of left ventricular non-compaction (LVNC).
  • To highlight the diagnostic challenges and clinical variability of LVNC.
  • To emphasize the need for further research and multicenter registries.

Main Methods:

  • Literature review of existing studies on LVNC.
  • Analysis of diagnostic criteria and imaging techniques (echocardiography, cardiac MRI).
  • Discussion of clinical presentations, complications, and management strategies.

Main Results:

  • LVNC diagnosis relies on imaging, but definitions vary.
  • Clinical manifestations range from asymptomatic to severe heart failure.
  • Common complications include heart failure, arrhythmias, and embolism.

Conclusions:

  • There is no specific therapy for LVNC; management is symptomatic.
  • Multicenter registries are crucial for a better understanding of LVNC.
  • Further research is needed to establish standardized definitions and improve patient outcomes.

Keywords:
CardiomyopathyHeart failureLeft ventricular non-compaction

More Related Videos

Isolation, Culture, and Functional Characterization of Adult Mouse Cardiomyoctyes12:49

Isolation, Culture, and Functional Characterization of Adult Mouse Cardiomyoctyes

Published on: September 24, 2013

25.6K
Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.5K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
887
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
939
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
811
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
513